AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Here Comes the Booming Chinese Biotech Sector
Odd Lots
Contrasting Drug Development: China vs. U.S. Regulatory Dynamics
This chapter explores the differences in drug development regulations between China and the United States, focusing on the advantages of China's quicker patient access through phase zero studies. It also examines the challenges and financial aspects of conducting clinical trials in the U.S., highlighting the disparities in healthcare systems and incentives for medical professionals.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode